{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:26:44Z","timestamp":1772749604452,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["SFRH\/BD\/97099\/2013"],"award-info":[{"award-number":["SFRH\/BD\/97099\/2013"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["SFRH\/BPD\/77900\/2011"],"award-info":[{"award-number":["SFRH\/BPD\/77900\/2011"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["CEECIND\/01463\/2017"],"award-info":[{"award-number":["CEECIND\/01463\/2017"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["FCOMP-01-0124-FEDER-027569"],"award-info":[{"award-number":["FCOMP-01-0124-FEDER-027569"]}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cluster of Excellence Unifying Systems in Catalysis"},{"name":"Centro de Estudos do Ambiente e do Mar","award":["UIDP\/50017\/2020"],"award-info":[{"award-number":["UIDP\/50017\/2020"]}]},{"name":"Centro de Estudos do Ambiente e do Mar","award":["UIDB\/50017\/2020"],"award-info":[{"award-number":["UIDB\/50017\/2020"]}]},{"DOI":"10.13039\/100007689","name":"Universidade de Aveiro","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007689","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n                <jats:title>Abstract\n<\/jats:title>\n                <jats:p>The enzymatic machinery involved in the biosynthesis of lantibiotic is an untapped source of proteases with different specificities. Lanthipeptide biosynthesis requires proteolysis of specific target sequences by known proteases, which are encoded by contiguous genes. Herein, the activity of lichenicidin A2 (LicA2) trimming proteases (LicP and LicT) was investigated in vivo. Firstly, the impact of some residues and the size of the peptide were evaluated. Then followed trials in which LicA2 leader was evaluated as a tag to direct production and secretion of other relevant peptides. Our results show that a negatively charged residue (preferably Glu) at cleavage site is important for LicP efficacy. Some mutations of the lichenicidin hexapeptide such as Val-4Ala, Asp-5Ala, Asn-6Ser, and the alteration of GG-motif to GA resulted in higher processing rates, indicating the possibility of improved lichenicidin production in <jats:italic>Escherichia coli<\/jats:italic>. More importantly, insulin A, amylin (non-lanthipeptides), and epidermin were produced and secreted to <jats:italic>E. coli<\/jats:italic> supernatant, when fused to the LicA2 leader peptide. This work aids in clarifying the activity of lantibiotic-related transporters and proteases and to evaluate their possible application in industrial processes of relevant compounds, taking advantage of the potential of microorganisms as biofactories.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key points<\/jats:title>\n                <jats:p>\u2022 <jats:italic>LicM2 correct activity implies a negatively charged residue at position -1<\/jats:italic>.<\/jats:p>\n                <jats:p>\u2022 <jats:italic>Hexapeptide mutations can increase the amount of fully processed Bli\u03b2<\/jats:italic>.<\/jats:p>\n                <jats:p>\u2022 <jats:italic>LicA2 leader peptide directs LicTP cleavage and secretion of other peptides<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00253-023-12388-5","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T16:51:23Z","timestamp":1676047883000},"page":"1687-1696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Class II two-peptide lanthipeptide proteases: exploring LicTP for biotechnological applications"],"prefix":"10.1007","volume":"107","author":[{"given":"Joana C.","family":"Barbosa","sequence":"first","affiliation":[]},{"given":"Eva","family":"M\u00f6sker","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Faria","sequence":"additional","affiliation":[]},{"given":"Roderich D.","family":"S\u00fcssmuth","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5057-5660","authenticated-orcid":false,"given":"S\u00f3nia","family":"Mendo","sequence":"additional","affiliation":[]},{"given":"T\u00e2nia","family":"Caetano","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"key":"12388_CR1","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/anie.198510511","volume":"24","author":"H Allgaier","year":"1985","unstructured":"Allgaier H, Jung G, Werner RG, Schneider U, Z\u00e4hner H (1985) Elucidation of the structure of epidermin, a ribosomally synthesized, tetracyclic heterodetic polypeptide antibiotic. Angew Chemie Int Ed English 24:1051\u20131053. https:\/\/doi.org\/10.1002\/anie.198510511","journal-title":"Angew Chemie Int Ed English"},{"key":"12388_CR2","doi-asserted-by":"publisher","unstructured":"Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, Camarero JA, Campopiano DJ, Challis GL, Clardy J, Cotter PD, Craik DJ, Dawson M, Dittmann E, Donadio S, Dorrestein PC, Entian K-D, Fischbach M a, Garavelli JS, G\u00f6ransson U, Gruber CW, Haft DH, Hemscheidt TK, Hertweck C, Hill C, Horswill AR, Jaspars M, Kelly WL, Klinman JP, Kuipers OP, Link a J, Liu W, Marahiel MA, Mitchell DA, Moll GN, Moore BS, M\u00fcller R, Nair SK, Nes IF, Norris GE, Olivera BM, Onaka H, Patchett ML, Piel J, Reaney MJT, Rebuffat S, Ross RP, Sahl H-G, Schmidt EW, Selsted ME, Severinov K, Shen B, Sivonen K, Smith L, Stein T, S\u00fcssmuth RD, Tagg JR, Tang G-L, Truman AW, Vederas JC, Walsh CT, Walton JD, Wenzel SC, Willey JM, van der Donk WA (2013) Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep 30:108\u201360. https:\/\/doi.org\/10.1039\/c2np20085f","DOI":"10.1039\/c2np20085f"},{"key":"12388_CR3","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1021\/np500424y","volume":"78","author":"J Barbosa","year":"2015","unstructured":"Barbosa J, Caetano T, Mendo S (2015) Class I and class II Lanthipeptides produced by Bacillus spp. J Nat Prod 78:2850\u20132866. https:\/\/doi.org\/10.1021\/np500424y","journal-title":"J Nat Prod"},{"key":"12388_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/bit.27130","author":"J Barbosa","year":"2019","unstructured":"Barbosa J, Caetano T, Moesker E, Suessmuth RD, Mendo S (2019) Lichenicidin rational site-directed mutagenesis library: a tool to generate bioengineered lantibiotics. Biotechnol Bioeng. https:\/\/doi.org\/10.1002\/bit.27130","journal-title":"Biotechnol Bioeng"},{"key":"12388_CR5","doi-asserted-by":"publisher","first-page":"112308","DOI":"10.1016\/j.colsurfb.2021.112308","volume":"211","author":"JC Barbosa","year":"2022","unstructured":"Barbosa JC, Gon\u00e7alves S, Makowski M, Silva \u00cdC, Caetano T, Schneider T, M\u00f6sker E, S\u00fcssmuth RD, Santos NC, Mendo S (2022) Insights into the mode of action of the two-peptide lantibiotic lichenicidin. Colloids Surf B Biointerfaces 211:112308. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.112308","journal-title":"Colloids Surf B Biointerfaces"},{"key":"12388_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11274-021-03196-y","volume":"38","author":"JC Barbosa","year":"2022","unstructured":"Barbosa JC, Silva \u00cdC, Caetano T, M\u00f6sker E, Seidel M, Louren\u00e7o J, S\u00fcssmuth RD, Santos NC, Gon\u00e7alves S, Mendo S (2022b) Assessing the potential of the two-peptide lantibiotic lichenicidin as a new generation antimicrobial. World J Microbiol Biotechnol 38:18. https:\/\/doi.org\/10.1007\/s11274-021-03196-y","journal-title":"World J Microbiol Biotechnol"},{"key":"12388_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3126\/jist.v21i1.16063","volume":"21","author":"S Basi-Chipalu","year":"2016","unstructured":"Basi-Chipalu S (2016) A review: lantibiotics, a promising antimicrobial agent. J Inst Sci Technol 21:119\u2013128. https:\/\/doi.org\/10.3126\/jist.v21i1.16063","journal-title":"J Inst Sci Technol"},{"key":"12388_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1574-6968.1995.tb07460.x","volume":"127","author":"G Bierbaum","year":"1995","unstructured":"Bierbaum G, Brotz H, Koller K-P, Sahl H-G (1995) Cloning, sequencing and production of the lantibiotic mersacidin. FEMS Microbiol Lett 127:121\u2013126","journal-title":"FEMS Microbiol Lett"},{"key":"12388_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.chembiol.2010.11.010","volume":"18","author":"T Caetano","year":"2011","unstructured":"Caetano T, Krawczyk JM, M\u00f6sker E, S\u00fcssmuth RD, Mendo S (2011) Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli. Chem Biol 18:90\u2013100. https:\/\/doi.org\/10.1016\/j.chembiol.2010.11.010","journal-title":"Chem Biol"},{"key":"12388_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1574-6968.2001.tb10511.x","volume":"195","author":"P Chen","year":"2001","unstructured":"Chen P, Qi F, Novak J, Krull RE, Caufield PW (2001) Effect of amino acid substitutions in conserved residues in the leader peptide on biosynthesis of the lantibiotic mutacin II. FEMS Microbiol Lett 195:139\u2013144. https:\/\/doi.org\/10.1111\/j.1574-6968.2001.tb10511.x","journal-title":"FEMS Microbiol Lett"},{"key":"12388_CR11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.chembiol.2008.07.020","volume":"15","author":"LE Cooper","year":"2008","unstructured":"Cooper LE, McClerren AL, Chary A, van der Donk WA (2008) Structure-activity relationship studies of the two-component lantibiotic haloduracin. Chem Biol 15:1035\u20131045. https:\/\/doi.org\/10.1016\/j.chembiol.2008.07.020","journal-title":"Chem Biol"},{"key":"12388_CR12","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1128\/jb.178.15.4472-4483.1996","volume":"178","author":"DB Diep","year":"1996","unstructured":"Diep DB, Nes IF (1996) Characterization of the locus responsible for the bacteriocin production in Lactobacillus plantarum C11. J Bacteriol 178:4472","journal-title":"J Bacteriol"},{"key":"12388_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijmm.2013.09.003","volume":"304","author":"J Dischinger","year":"2014","unstructured":"Dischinger J, BasiChipalu S, Bierbaum G (2014) Lantibiotics: promising candidates for future applications in health care. Int J Med Microbiol 304:51\u201362. https:\/\/doi.org\/10.1016\/j.ijmm.2013.09.003","journal-title":"Int J Med Microbiol"},{"key":"12388_CR14","doi-asserted-by":"publisher","first-page":"e6788","DOI":"10.1371\/journal.pone.0006788","volume":"4","author":"J Dischinger","year":"2009","unstructured":"Dischinger J, Josten M, Szekat C, Sahl H-G, Bierbaum G (2009) Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLoS One 4:e6788. https:\/\/doi.org\/10.1371\/journal.pone.0006788","journal-title":"PLoS One"},{"key":"12388_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2015.01363","volume":"6","author":"D Field","year":"2015","unstructured":"Field D, Cotter PD, Hill C, Ross RP (2015) Bioengineering lantibiotics for therapeutic success. Front Microbiol 6:1\u20138. https:\/\/doi.org\/10.3389\/fmicb.2015.01363","journal-title":"Front Microbiol"},{"key":"12388_CR16","doi-asserted-by":"publisher","first-page":"7352","DOI":"10.1021\/bi800278n","volume":"47","author":"LA FurgersonIhnken","year":"2008","unstructured":"FurgersonIhnken LA, Chatterjee C, van der Donk WA (2008) In vitro reconstitution and substrate specificity of a lantibiotic protease. Biochem 47:7352\u20137363. https:\/\/doi.org\/10.1021\/bi800278n","journal-title":"Biochem"},{"key":"12388_CR17","doi-asserted-by":"publisher","unstructured":"G\u00f6ddel D V, Kleid DG, Bolivar F, Heyneker HL, Yansura DG, Crea R, Hirose T, Kraszewski A, Itakura K, Riggs AD (1979) Expression in Escherichia coli of chemically synthesized genes for human insulin. Proc Natl Acad Sci U S A 76:106\u201310. https:\/\/doi.org\/10.1073\/pnas.76.1.106","DOI":"10.1073\/pnas.76.1.106"},{"key":"12388_CR18","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1126\/science.412251","volume":"198","author":"K Itakura","year":"1977","unstructured":"Itakura K, Hirose T, Crea R, Riggs AD, Heyneker HL, Boyer HW (1977) Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science (80-) 198:1056","journal-title":"Science (80-)"},{"key":"12388_CR19","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S1074-5521(00)00034-X","volume":"7","author":"M Krampert","year":"2000","unstructured":"Krampert M, Bernhagen J, Schmucker J, Horn A, Schmauder A, Brunner H, Voelter W, Kapurniotu A (2000) Amyloidogenicity of recombinant human pro-islet amyloid polypeptide (ProIAPP). Chem Biol 7:855\u2013871. https:\/\/doi.org\/10.1016\/S1074-5521(00)00034-X","journal-title":"Chem Biol"},{"key":"12388_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1574-6968.1993.tb06421.x","volume":"112","author":"T Kupke","year":"1993","unstructured":"Kupke T, Stevanovic S, Ottenw\u00e4lder B, Metzger JW, Jung G, G\u00f6tz F (1993) Purification and characterization of EpiA, the peptide substrate for post-translational modifications involved in epidermin biosynthesis. FEMS Microbiol Lett 112:43\u201348. https:\/\/doi.org\/10.1111\/j.1574-6968.1993.tb06421.x","journal-title":"FEMS Microbiol Lett"},{"key":"12388_CR21","doi-asserted-by":"publisher","unstructured":"Kuthning A, M\u00f6sker E, S\u00fcssmuth RD (2015) Engineering the heterologous expression of lanthipeptides in Escherichia coli by multigene assembly. Appl Microbiol Biotechnol. https:\/\/doi.org\/10.1007\/s00253-015-6557-6","DOI":"10.1007\/s00253-015-6557-6"},{"key":"12388_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1475-2859-11-28","volume":"11","author":"S Kyle","year":"2012","unstructured":"Kyle S, AR James K, McPherson MJ (2012) Recombinant production of the therapeutic peptide lunasin. Microb Cell Fact 11:28. https:\/\/doi.org\/10.1186\/1475-2859-11-28","journal-title":"Microb Cell Fact"},{"key":"12388_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1574-6968.2006.00539.x","volume":"267","author":"EM Lawton","year":"2007","unstructured":"Lawton EM, Cotter PD, Hill C, Ross RP (2007) Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125. FEMS Microbiol Lett 267:64\u201371. https:\/\/doi.org\/10.1111\/j.1574-6968.2006.00539.x","journal-title":"FEMS Microbiol Lett"},{"key":"12388_CR24","doi-asserted-by":"publisher","first-page":"42803","DOI":"10.1074\/jbc.M406108200","volume":"279","author":"DHJ Lopes","year":"2004","unstructured":"Lopes DHJ, Colin C, Degaki TL, de Sousa ACV, Vieira MNN, Sebollela A, Martinez AMB, Bloch C, Ferreira ST, Sogayar MC (2004) Amyloidogenicity and cytotoxicity of recombinant mature human islet amyloid polypeptide (rhIAPP). J Biol Chem 279:42803\u201342810. https:\/\/doi.org\/10.1074\/jbc.M406108200","journal-title":"J Biol Chem"},{"key":"12388_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fnins.2015.00216","volume":"9","author":"TA Lutz","year":"2015","unstructured":"Lutz TA, Meyer U (2015) Amylin at the interface between metabolic and neurodegenerative disorders. Front Neurosci 9:216. https:\/\/doi.org\/10.3389\/fnins.2015.00216","journal-title":"Front Neurosci"},{"key":"12388_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12033-013-9667-3","volume":"55","author":"S Maicas","year":"2013","unstructured":"Maicas S, Moukadiri I, Nieto A, Valent\u00edn E (2013) Construction of an expression vector for production and purification of human somatostatin in Escherichia coli. Mol Biotechnol 55:150\u2013158. https:\/\/doi.org\/10.1007\/s12033-013-9667-3","journal-title":"Mol Biotechnol"},{"key":"12388_CR27","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0022-2836(02)00887-2","volume":"322","author":"Y Mazor","year":"2002","unstructured":"Mazor Y, Gilead S, Benhar I, Gazit E (2002) Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide. J Mol Biol 322:1013\u20131024. https:\/\/doi.org\/10.1016\/S0022-2836(02)00887-2","journal-title":"J Mol Biol"},{"key":"12388_CR28","first-page":"76","volume":"436","author":"WL Miller","year":"1980","unstructured":"Miller WL, Baxter JD (1980) Recombinant DNA - a new source of insulin. Diabetol 436:76\u201379","journal-title":"Diabetol"},{"key":"12388_CR29","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1021\/pr050401j","volume":"5","author":"MP Nandakumar","year":"2006","unstructured":"Nandakumar MP, Cheung A, Marten MM (2006) Proteomic analysis of extracellular proteins from Escherichia coli W3110. J Proteome Res 5:1155\u20131161. https:\/\/doi.org\/10.1021\/pr050401j","journal-title":"J Proteome Res"},{"key":"12388_CR30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1128\/AAC.35.5.998.Updated","volume":"35","author":"W Niu","year":"1991","unstructured":"Niu W, Neu HC (1991) Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin. Antimicrob Agents Chemother 35:998\u20131000. https:\/\/doi.org\/10.1128\/AAC.35.5.998.Updated","journal-title":"Antimicrob Agents Chemother"},{"key":"12388_CR31","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1021\/cb900194x","volume":"4","author":"TJ Oman","year":"2009","unstructured":"Oman TJ, van der Donk WA (2009) Insights into the mode of action of the two-peptide lantibiotic haloduracin. ACS Chem Biol 4:865\u2013874. https:\/\/doi.org\/10.1021\/cb900194x","journal-title":"ACS Chem Biol"},{"key":"12388_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12602-015-9193-7","volume":"7","author":"G Pal","year":"2015","unstructured":"Pal G, Srivastava S (2015) Scaling up the production of recombinant antimicrobial plantaricin E from a heterologous host, Escherichia coli. Probiotics Antimicrob Proteins 7:216\u2013221. https:\/\/doi.org\/10.1007\/s12602-015-9193-7","journal-title":"Probiotics Antimicrob Proteins"},{"key":"12388_CR33","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00253-013-5097-1","volume":"98","author":"G Pal","year":"2014","unstructured":"Pal G, Srivastava S (2014) Cloning and heterologous expression of plnE, -F, -J and -K genes derived from soil metagenome and purification of active plantaricin peptides. Appl Microbiol Biotechnol 98:1441\u20131447. https:\/\/doi.org\/10.1007\/s00253-013-5097-1","journal-title":"Appl Microbiol Biotechnol"},{"key":"12388_CR34","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1021\/acs.chemrev.6b00591","volume":"117","author":"LM Repka","year":"2017","unstructured":"Repka LM, Chekan JR, Nair SK, van der Donk WA (2017) Mechanistic understanding of lanthipeptide biosynthetic enzymes. Chem Rev 117:5457\u20135520. https:\/\/doi.org\/10.1021\/acs.chemrev.6b00591","journal-title":"Chem Rev"},{"key":"12388_CR35","doi-asserted-by":"publisher","first-page":"6462","DOI":"10.1021\/bi100871b","volume":"49","author":"ZO Shenkarev","year":"2010","unstructured":"Shenkarev ZO, Finkina EI, Nurmukhamedova EK, Balandin SV, Mineev KS, Nadezhdin KD, Yakimenko ZA, Tagaev AA, Temirov YV, Arseniev AS, Ovchinnikova TV (2010) Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21. Biochem 49:6462\u20136472. https:\/\/doi.org\/10.1021\/bi100871b","journal-title":"Biochem"},{"key":"12388_CR36","doi-asserted-by":"publisher","first-page":"11884","DOI":"10.1021\/jacs.8b05544","volume":"140","author":"T Si","year":"2018","unstructured":"Si T, Tian Q, Min Y, Zhang L, Sweedler JV, van der Donk WA, Zhao H (2018) Rapid screening of lanthipeptide analogs via in-colony removal of leader peptides in Escherichia coli. J Am Chem Soc 140:11884\u201311888. https:\/\/doi.org\/10.1021\/jacs.8b05544","journal-title":"J Am Chem Soc"},{"key":"12388_CR37","doi-asserted-by":"publisher","first-page":"6270","DOI":"10.1039\/C5SC02329G","volume":"6","author":"W Tang","year":"2015","unstructured":"Tang W, Dong S-H, Repka LM, He C, Nair SK, van der Donk WA (2015) Applications of the class II lanthipeptide protease LicP for sequence-specific, traceless peptide bond cleavage. Chem Sci 6:6270\u20136279. https:\/\/doi.org\/10.1039\/C5SC02329G","journal-title":"Chem Sci"},{"key":"12388_CR38","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1128\/AEM.71.1.562-565.2005","volume":"71","author":"P Uguen","year":"2005","unstructured":"Uguen P, Hindr\u00e9 T, Didelot S, Marty C, Haras D, Le Pennec J-P, Vall\u00e9e-R\u00e9hel K, Dufour A (2005) Maturation by LctT is required for biosynthesis of full-length lantibiotic lacticin 481. Appl Environ Microbiol 71:562\u2013565. https:\/\/doi.org\/10.1128\/AEM.71.1.562-565.2005","journal-title":"Appl Environ Microbiol"},{"key":"12388_CR39","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1517\/17425255.2011.573478","volume":"7","author":"AJ van Heel","year":"2011","unstructured":"van Heel AJ, Montalban-Lopez M, Kuipers OP (2011) Evaluating the feasibility of lantibiotics as an alternative therapy against bacterial infections in humans. Expert Opin Drug Metab Toxicol 7:675\u2013680. https:\/\/doi.org\/10.1517\/17425255.2011.573478","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"12388_CR40","doi-asserted-by":"publisher","unstructured":"van Staden ADP, van Zyl WF, Trindade M, Dicks LMT, Smith C (2021) Therapeutic application of lantibiotics and other lanthipeptides: old and new findings. Appl Environ Microbiol 87. https:\/\/doi.org\/10.1128\/AEM.00186-21","DOI":"10.1128\/AEM.00186-21"},{"key":"12388_CR41","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1128\/AEM.03751-13","volume":"80","author":"J Wang","year":"2014","unstructured":"Wang J, Zhang L, Teng K, Sun S, Sun Z, Zhong J (2014) Cerecidins, novel lantibiotics from Bacillus cereus with potent antimicrobial activity. Appl Environ Microbiol 80:2633. https:\/\/doi.org\/10.1128\/AEM.03751-13","journal-title":"Appl Environ Microbiol"},{"key":"12388_CR42","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/pro.211","volume":"18","author":"IT Yonemoto","year":"2009","unstructured":"Yonemoto IT, Wood MR, Balch WE, Kelly JW (2009) A general strategy for the bacterial expression of amyloidogenic peptides using BCL-XL-1\/2 fusions. Protein Sci 18:1978\u20131986. https:\/\/doi.org\/10.1002\/pro.211","journal-title":"Protein Sci"},{"key":"12388_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/1615-1003(200101)30:1<27::AID-PAUZ27>3.0.CO;2-S","volume":"30","author":"I Z\u00fcndorf","year":"2001","unstructured":"Z\u00fcndorf I, Dingermann T (2001) Bereitstellung ausreichender mengen von humaninsulin: Vom rinder-, schweine-, pferde- insulin zum humaninsulin: Die biotechnische und gen-technische insulin-herstellung. Pharm Unserer Zeit 30:27\u201332. https:\/\/doi.org\/10.1002\/1615-1003(200101)30:1%3c27::AID-PAUZ27%3e3.0.CO;2-S","journal-title":"Pharm Unserer Zeit"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-023-12388-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-023-12388-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-023-12388-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T07:07:56Z","timestamp":1678432076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-023-12388-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":43,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["12388"],"URL":"https:\/\/doi.org\/10.1007\/s00253-023-12388-5","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]},"assertion":[{"value":"5 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}